Our pilot study confirms the effectiveness of YKL-40 as an early diagnostic biomarker of neonatal sepsis in term neonates, although YKL-40 levels did not differentiate between culture-positive and culture-negative sepsis in our study sample. The gene discussed is CHI3L1; the disease is Sepsis.